Blog
RSS FeedPosted by Michael Wonder on 18 Dec 2017
Time for big pharma to step up before the drug price debate rises again
18 December 2017 - In today’s social and political climate, public opinion and public action can galvanise and turn on an ...
Posted by Michael Wonder on 18 Dec 2017
FDA accepts biologics license application for fremanezumab with priority review for prevention of migraine and grants fast track designation for cluster headache development program
18 December 2017 - Teva anticipates launching anti-CGRP product in the U.S. for the prevention of migraine in 2018. ...
Posted by Michael Wonder on 18 Dec 2017
US FDA accepts regulatory submission for Tagrisso in first-line EGFR-mutated non-small cell lung cancer
18 December 2017 - Tagrisso granted priority review. ...
Posted by Michael Wonder on 18 Dec 2017
Looking north: can a single-payer health system work in the U.S.?
18 December 2017 - For Dr. Peter Cram, an American internist who spent most of his career practicing in Iowa ...
Posted by Michael Wonder on 18 Dec 2017
Humana in talks to buy Kindred Healthcare with equity firms
18 December 2017 - U.S. health insurer Humana is in advanced talks to acquire acute care provider Kindred Healthcare in ...
Posted by Michael Wonder on 17 Dec 2017
Novel cancer drug gets stymied by Medicare rigid billing system
16 December 2017 - Annual code updates take ‘too long’ for patients, doctors. ...
Posted by Michael Wonder on 17 Dec 2017
WTX101 granted fast track designation by the U.S. FDA for the treatment of Wilson disease
14 December 2017 - Wilson Therapeutics today announced that the U.S. FDA has granted WTX101 fast track designation for the treatment ...
Posted by Michael Wonder on 17 Dec 2017
US FDA grants fast track designation to Renova Therapeutics’ RT-100 AC6 gene transfer for the treatment of heart failure
14 December 2107 - FLOURISH Phase 3 clinical trial in patients with heart failure and reduced ejection fraction to begin ...
Posted by Michael Wonder on 15 Dec 2017
FDA targets insulin for increased competition to lower prices
16 December 2017 - Prices of the diabetes medicine have risen 270%. ...
Posted by Michael Wonder on 15 Dec 2017
An open-source consensus-based approach to value assessment
15 December 2017 - Value Assessment? Yes, But How? ...
Posted by Michael Wonder on 15 Dec 2017
Statement from FDA Commissioner on new FDA efforts to support more efficient development of targeted therapies
15 December 2017 - In recent years, the medical community has experienced a shift in the way health care is ...
Posted by Michael Wonder on 15 Dec 2017
Strong demand for health insurance as deadline looms
13 December 2017 - More than one million people signed up last week for health insurance under the Affordable Care ...
Posted by Michael Wonder on 15 Dec 2017
Institute for Clinical and Economic Review to assess elagolix for management of endometriosis
14 December 2017 - Open input now being accepted until 8 January 2018. ...
Posted by Michael Wonder on 15 Dec 2017
Amicus Therapeutics submits new drug application to U.S. FDA for migalastat for treatment of Fabry Disease
14 December 2017 - Amicus Therapeutics submitted a new drug application to the U.S. FDA to request approval of the ...
Posted by Michael Wonder on 14 Dec 2017
New steps to facilitate beneficial medical device innovation
14 December 2017 - In recent days, the FDA has committed to several new policies that will modernise the agency’s approach ...